WallStreetZenWallStreetZen

NASDAQ: WGS
Genedx Holdings Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for WGS

Based on 6 analysts offering 12 month price targets for Genedx Holdings Corp

Min Forecast
$78.00-5.52%
Avg Forecast
$95.50+15.67%
Max Forecast
$115.00+39.29%

Should I buy or sell WGS stock?

Based on 6 analysts offering ratings for Genedx Holdings Corp.

Strong Buy
Strong Buy
4 analysts 66.67%
Buy
0 analysts 0%
Hold
2 analysts 33.33%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although WGS's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates WGS as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their WGS stock forecasts and price targets.

WGS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-07-09
lockedlocked$00.00+00.00%2025-06-30
lockedlocked$00.00+00.00%2025-05-09
lockedlocked$00.00+00.00%2025-05-01
lockedlocked$00.00+00.00%2025-05-01
Goldman Sachs
Top 10%
91
HoldMaintains$80.00-3.10%2025-02-19

1 of 1

Forecast return on equity

Is WGS forecast to generate an efficient return?

Company
N/A
Industry
13.21%
Market
67.12%

Forecast return on assets

Is WGS forecast to generate an efficient return on assets?

Company
N/A
Industry
10.35%

WGS earnings per share forecast

What is WGS's earnings per share in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
$0.99
Avg 2 year Forecast
$2.18

WGS revenue forecast

What is WGS's revenue in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
$371.3M+12.47%
Avg 2 year Forecast
$441.0M+33.56%
Avg 3 year Forecast
$514.0M+55.69%
WGS's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

WGS revenue growth forecast

How is WGS forecast to perform vs Health Information Services companies and vs the US market?

Company
15.7%
Industry
8.92%
Market
10.56%
WGS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
WGS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

WGS vs Health Information Service Stocks

TickerPricePrice TargetUp/downsideConsensus
WGS$82.56$95.50+15.67%Strong Buy
PRVA$20.47$29.89+46.01%Strong Buy
PGNY$23.21$25.00+7.71%Buy
CERT$11.09$15.60+40.67%Buy
PINC$21.08$22.67+7.53%Hold
View Top Health Information Service Stocks

Genedx Holdings Stock Forecast FAQ

Is Genedx Holdings Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 6 Wall Street analysts covering (NASDAQ: WGS) stock is to Strong Buy WGS stock.

Out of 6 analysts, 4 (66.67%) are recommending WGS as a Strong Buy, 0 (0%) are recommending WGS as a Buy, 2 (33.33%) are recommending WGS as a Hold, 0 (0%) are recommending WGS as a Sell, and 0 (0%) are recommending WGS as a Strong Sell.

If you're new to stock investing, here's how to buy Genedx Holdings stock.

What is WGS's earnings growth forecast for 2025-2026?

(NASDAQ: WGS) Genedx Holdings's forecast annual earnings growth rate of N/A is not forecast to beat the US Health Information Services industry's average forecast earnings growth rate of 19.25%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 20.14%.

Genedx Holdings's earnings in 2025 is -$38,576,000.On average, 1 Wall Street analyst forecast WGS's earnings for 2025 to be $28,247,872, with the lowest WGS earnings forecast at $28,247,872, and the highest WGS earnings forecast at $28,247,872.

In 2026, WGS is forecast to generate $62,202,385 in earnings, with the lowest earnings forecast at $62,202,385 and the highest earnings forecast at $62,202,385.

What is WGS's revenue growth forecast for 2025-2027?

(NASDAQ: WGS) Genedx Holdings's forecast annual revenue growth rate of 15.7% is forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 8.92%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.56%.

Genedx Holdings's revenue in 2025 is $330,143,000.On average, 2 Wall Street analysts forecast WGS's revenue for 2025 to be $10,594,378,645, with the lowest WGS revenue forecast at $10,528,752,276, and the highest WGS revenue forecast at $10,660,005,014. On average, 2 Wall Street analysts forecast WGS's revenue for 2026 to be $12,581,716,304, with the lowest WGS revenue forecast at $12,540,343,158, and the highest WGS revenue forecast at $12,623,089,450.

In 2027, WGS is forecast to generate $14,666,066,856 in revenue, with the lowest revenue forecast at $14,666,066,856 and the highest revenue forecast at $14,666,066,856.

What is WGS's forecast return on assets (ROA) for 2025-2027?

(NASDAQ: WGS) forecast ROA is N/A, which is lower than the forecast US Health Information Services industry average of 10.35%.

What is WGS's Price Target?

According to 6 Wall Street analysts that have issued a 1 year WGS price target, the average WGS price target is $95.50, with the highest WGS stock price forecast at $115.00 and the lowest WGS stock price forecast at $78.00.

On average, Wall Street analysts predict that Genedx Holdings's share price could reach $95.50 by Jul 9, 2026. The average Genedx Holdings stock price prediction forecasts a potential upside of 15.67% from the current WGS share price of $82.56.

What is WGS's Earnings Per Share (EPS) forecast for 2025-2026?

(NASDAQ: WGS) Genedx Holdings's current Earnings Per Share (EPS) is -$1.41. On average, analysts forecast that WGS's EPS will be $0.99 for 2025, with the lowest EPS forecast at $0.99, and the highest EPS forecast at $0.99. In 2026, WGS's EPS is forecast to hit $2.18 (min: $2.18, max: $2.18).

What is WGS's forecast return on equity (ROE) for 2025-2027?

(NASDAQ: WGS) forecast ROE is N/A, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.